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Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Acinetobacter 
baumannii (CRAB) are the leading causes of nosocomial infections. A rapid and sensitive 
test to detect CRPA and CRAB is required for appropriate antibiotic treatment. We opti-
mized a loop-mediated isothermal amplification (LAMP) assay to detect the presence of 
blaVIM-2, blaIMP-1, and blaOXA-23, which are critical components for carbapenem resistance. 
Methods: Two sets of primers, inner and outer primers, were manually designed as previ-
ously described. The LAMP buffer was optimized (at 2mM MgSO4) by testing different 
concentrations of MgSO4. The optimal reaction temperature and incubation time were de-
termined by using a gradient thermocycler. Then, the optimized blaVIM-2, blaIMP-1, and bla-
OXA-23 LAMP reactions were evaluated by using 120 P. aeruginosa and 99 A. baumannii 
clinical isolates.
Results: Only one strain of the 100 CRPA isolates harbored blaIMP-1, whereas none of them 
harbored blaVIM-2. These results indicate that the acquisition of blaVIM-2 or blaIMP-1 may not 
play a major role in carbapenem resistance in Korea. Fifty two strains of the 75 CRAB iso-
lates contained blaOXA-23, but none contained blaVIM-2 and blaIMP-1 alleles.
Conclusions: Our results demonstrate the usefulness of LAMP for the diagnosis of CRPA 
and CRAB.
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INTRODUCTION
Pseudomonas aeruginosa and Acinetobacter baumannii cause 
a wide range of opportunistic infections and nosocomial out-
breaks with high mortality [1-3]. Nosocomial infections are usu-
ally caused by multidrug-resistant P. aeruginosa (MRPA) and A. 
baumannii (MRAB), and their multidrug resistance makes cur-
ing infected patients very difficult. Although carbapenems are 
the last line of treatment for infections caused by multidrug-re-
sistant bacteria, some organisms can acquire carbapenem re-
sistance. Based on recent reports, carbapenemase-producing 
clinical isolates of P. aeruginosa and A. baumannii have been 
steadily reported around the world. Even in Korea, healthcare-
associated infections caused by multidrug-resistant pathogens 
have become a significant clinical concern [4-8]. Following this 
trend, since 2012, six multidrug-resistant organisms were des-
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ignated as the source of healthcare-associated infections by the 
Korea Centers for Disease Control and Prevention, and MRPA 
and MRAB strains associated with carbapenem resistance were 
included among these six strains [9].
Carbapenem resistance is induced by the expression of car-
bapenemase. Carbapenemases are versatile β-lactamases that 
have the ability to hydrolyze penicillins, cephalosporins, mono-
bactams. Carbapenems exhibit a broader spectrum of antibac-
terial activity towards Gram-positive and Gram-negative bacteria 
than other β-lactams [10]. To detect carbapenemase-producing 
P. aeruginosa and A. baumannii strains, blaVIM-2, blaIMP-1, and 
blaOXA-23 were chosen as target genes. blaVIM-2 and blaIMP-1 en-
code class B metallo-β-lactamases, and these genes have been 
detected in P. aeruginosa and A. baumannii. In contrast, bla-
OXA-23, which encodes a carbapenemase belonging to the class D 
β-lactamases, has been detected only in A. baumannii [1]. Test-
ing for blaVIM-2, blaIMP-1, and blaOXA-23 is important for the timely 
detection and treatment of carbapenem-resistant P. aeruginosa 
(CRPA) and A. baumannii (CRAB) infections.
Routine diagnostic methods for the detection of CRPA and 
CRAB have mainly included antibiotic sensitivity testing (e.g., 
modified Hodge test [MHT]), carbapenemase-inhibition testing 
(e.g., double disk synergy test [DDST]), and the use of auto-
mated instruments to determine the minimum inhibitory con-
centration (MIC) of antibiotics (e.g., Vitek, MicroScan, and 
Phoenix) [11-14]. However, most routine diagnostic methods 
are culture-based assays that require 16-24 hr to complete. 
This causes a delay in diagnosis and subsequent effective treat-
ment of infected patients.
Loop-mediated isothermal amplification (LAMP) has been 
widely used in microbial diagnoses for several reasons, includ-
ing its simple methodology, short reaction time, and naked-eye 
detection of positive reactions [15]. In this study, we explored 
whether or not LAMP could be used for fast and convenient de-
tection of CRPA or CRAB in clinical specimens. To this end, we 
optimized the reaction conditions for LAMP-based detection of 
blaVIM-2, blaIMP-1, and blaOXA-23 alleles. The sensitivity and specific-
ity of the current LAMP protocol were superior to those of con-
ventional PCR methods.
METHODS
1. Bacterial strains and DNA extraction
All the bacterial strains used in this study were clinical isolates 
obtained from the Department of Laboratory Medicine, Yonsei 
University College of Medicine, Seoul, Korea. The positive con-
trol DNAs used in the optimization test were extracted from car-
bapenem-resistant strains that were confirmed to possess car-
bapenem-resistance genes by PCR. DNA from sputum isolates 
of CRPA (n=100) and carbapenem-susceptible P. aeruginosa 
(CSPA, n=20) and those of CRAB (n=75) and carbapenem-
susceptible A. baumannii (CSAB, n=24) were recovered by us-
ing the Geno-Auto Bacterial DNA Prep Kit (Genolution, Seoul, 
Korea, Catalogue No. RE1702). This kit includes unique mag-
netic beads with a DNA binding affinity that varies according to 
the pH of the buffer used. The magnetic beads bind DNA in low 
pH buffer and release DNA in high pH buffer. After setup, the 
time required to extract the DNA is 15-30 min, and the yield 
from these clinical specimens was quite high.
2. PCR assay for blaVIM-2, blaIMP-1, and blaOXA-23 alleles
Before the LAMP assay, the presence of carbapenemase-pro-
ducing genes in isolates was confirmed by PCR. Primers for 
blaVIM-2, blaIMP-1, and blaOXA-23 LAMP reactions were designed 
based on the NCBI database sequences of blaVIM-2 (801 bp, Gen-
Bank ID: NC_020452.1), bla IMP-1 (741 bp, GenBank ID: 
AP012280.1), and blaOXA-23 (822 bp, GenBank ID: GQ861438.1). 
PCR of blaVIM-2 and blaIMP-1 was performed by using the respec-
tive outer LAMP primers (Table 1). PCR primers for blaOXA-23 were 
generated by Primer3 software (http://bioinfo.ut.ee/primer3/) by 
using custom designed primer sets. All PCR primers were de-
signed in house, including the annealing sites of the LAMP prim-
ers. The primers used in the study are shown in Table 1. PCR re-
action was performed as previously described [15].
3.  LAMP reactions for the detection of blaVIM-2, blaIMP-1, and 
blaOXA-23 genes
The target gene sequences used to design the LAMP primers 
were identical to that used to design the PCR primers. However, 
the LAMP primers were different from the PCR primers. For the 
LAMP reactions, two sets of primers, inner and outer, are re-
quired. Although loop primers can also be included to shorten 
the reaction time, in this study, only inner and outer primers 
were used. The LAMP primer design method was identical to 
that described in a previous study [15]. Fig. 1 shows the DNA 
sequences of blaVIM-2, blaIMP-1, and blaOXA-23 and the locations of 
both the forward and backward inner and outer primers. The 
primer sets (shown in Table 1) amplified 147 bp (89-235), 187 
bp (116-302), and 191 bp (136-326) target sequences of 
blaVIM-2, blaIMP-1, and blaOXA-23 between the F2 and B2 regions, 
respectively (Fig. 1). The template for the LAMP reactions was 
genomic DNA that contains blaVIM-2, blaIMP-1, or blaOXA-23.
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To determine the most efficient conditions for the blaVIM-2, 
blaIMP-1, and blaOXA-23 LAMP reactions, a range of reaction tem-
peratures (57-68°C) was tested. To determine the optimal con-
centration of MgSO4, 10× LAMP buffer was made as described 
previously [15] containing various concentrations of MgSO4 
(Sigma-Aldrich Co., St. Louis, MO, USA). The 10× LAMP buffer 
with MgSO4 was diluted to 1× before use. The optimized reac-
tion buffer was also used to determine the lowest template DNA 
concentration that yielded detectable amplification products. 
Formation of a white precipitate (magnesium pyrophosphate 
[Mg2P2O7]) after centrifuging the PCR tubes at 15,328g for 2 
min was a criterion for a positive LAMP reaction. A positive re-
action was confirmed by running the reaction products on a 
1.5% agarose gel. All LAMP experiments were performed in 
triplicate.
RESULTS
1.  Optimization of the blaVIM-2, blaIMP-1, and blaOXA-23 LAMP 
reactions
To determine the optimal reaction temperature, LAMP reactions 
were performed at a range of temperatures from 57°C to 68°C 
for 1 hr. A distinct ladder-like band pattern, an indication of a 
successful LAMP amplification, was observed in all LAMP reac-
tions (Fig. 2A-C). Under our experimental conditions, positive 
LAMP reactions for blaVIM-2 and blaIMP-1 were observed at 57-
63°C, whereas for blaOXA-23, positive LAMP reactions were ob-
served at 57-62°C.
The optimal MgSO4 concentration for each reaction was also 
determined. At 63°C, the best amplification was observed at 2-5 
mM MgSO4 for blaVIM-2 and at 2-3mM MgSO4 for blaIMP-1 (Fig. 2D 
and E). The best amplification of blaOXA-23 was observed at 62°C 
and 1-2mM MgSO4 (Fig. 2F). These results indicated that the 
optimal MgSO4 concentration using our primers was 2mM for all 
reactions and that the optimal reaction temperatures were 63°C 
for blaVIM-2 and blaIMP-1 and 62°C for blaOXA-23.
2. Sensitivity of the LAMP reaction
To assess the limit of detection (LOD) for each LAMP reaction, 
LAMP assays were performed by using a series of DNA tem-
plate samples prepared from 10-fold serial dilutions of a stock 
with an initial concentration of 10 ng/μL. A typical ladder-like 
Table 1. Primers used in this study
Target gent Primer Sequence (5´ to 3´)
LAMP blaVIM-2 FIP GGCAATCTGGTAAAGCCGGACCTC-GCGGTGAGTATCCGACAGTCAGC
                   F1C                       F2
BIP GCAACGCAGTCGTTTGATGGCGC-CATCACCATCACGGACAATGAGACC
                   B1C                       B2
F3* CATGGCTATTGCGAGTCCGCTCG
B3* GCCGCTGTGTTTTTCGCACCCCA
 blaIMP-1 FIP GCCTCAGCATTTACAAGAACCACCA-CGTTTGAAGAAGTTAACGGGTGGGG
                   F1C                        F2
BIP AGTTAGTCACTTGGTTTGTGGAGCG-GTGCTGTCGCTATGAAAATGAGAGG
                   B1C                        B2
F3* TGTTTTGCAGCATTGCTACCGCAGC
B3* CGAGAATTAAGCCACTCTATTCCGC
 blaOXA-23 FIP CGCGGCTTAGAGCATTACCATATAG-GAAAAAAACACCTCAGGTGTGCTGG
                   F1C                         F2
BIP TGTTGAATGCCCTGATCGGATTGG-GACCTTTTCTCGCCCTTCCATTTAAAT
                   B1C                         B2
F3 AACCCCGAGTCAGATTGTTCAAGG
B3 GCTTCATGGCTTCTCCTAGTGTC
PCR blaOXA-23 F AAATGAAACCCCGAGTCAGA
R CCCAACCAGTCTTTCCAAAA
*The LAMP outer primers F3 and B3 were used in the PCRs for both blaVIM-2 and blaIMP-1.
Abbreviations: LAMP, loop-mediated isothermal amplification; FIP, forward inner primer; BIP, backward inner primer; F, forward; R, reverse.
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pattern was detected by using as little as 1 pg of target DNA for 
blaVIM-2 and 10 pg of target DNA for blaIMP-1 and blaOXA-23 (Fig. 
3A-C). We then compared the LOD for each target gene in con-
ventional PCR. 
As shown in Fig. 3A, 1 ng of DNA was required for PCR am-
plification of blaVIM-2. This indicates that for blaVIM-2, using our 
primer sets, a positive LAMP reaction could be obtained with 
1,000-fold less DNA template. Likewise, for blaIMP-1 and blaOXA-23, 
10-fold or 100-fold less DNA template was required to obtain a 
positive LAMP reaction (Fig. 3B and C).
Next, we assessed how fast a LAMP reaction can yield prod-
ucts that were detectable by the naked eye when using 10 ng of 
DNA template. Under our reaction conditions, a positive LAMP 
reaction for blaVIM-2 was achieved after a 20-min reaction (Fig. 
3D). Importantly, magnesium pyrophosphate (Mg2P2O7) precipi-
tate was clearly visible after a 25-min reaction (data not shown). 
For blaIMP-1 and blaOXA-23, positive reactions were detectable after 
35 min and 40 min, respectively (Fig. 3E and F). This finding is 
consistent with the sensitivity result shown in Fig. 3C. Among 
the three LAMP targets, blaVIM-2 was detectable with the smallest 
amount of template DNA.
3.  Application of blaVIM-2, blaIMP-1, and blaOXA-23 LAMP 
reactions for efficient detection of CRPA or CRAB in 
clinical isolates 
The optimized blaVIM-2, blaIMP-1, and blaOXA-23 LAMP reactions 
were evaluated by using clinical isolates. Of the 120 sputum 
isolates of P. aeruginosa tested, 100 were determined to be 
Fig. 1. Primers designed for blaVIM-2, blaIMP-1, and blaOXA-23 loop-mediated isothermal amplification (LAMP) assays. Nucleotide sequences of 
blaVIM-2 (A), blaIMP-1 (B), and blaOXA-23 (C) and the location of LAMP primers. The forward and backward inner primers are F1c-F2 and B1c-
B2 sequences, respectively. The forward and backward outer primers are F3 and B3, respectively.
A
B
C
blaVIM-2
blaIMP-1
blaOXA-23 
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CRPA based on their growth capabilities, while the other 20 iso-
lates were determined to be CSPA. Sputum isolates of A. bau-
mannii (N=99) were also tested; 75 were determined to be 
CRAB based on their growth capabilities, while the other 24 
strains were determined to be CSAB. DNA extracted by a mag-
netic bead-based method was used as a template. Among the 
100 CRPA strains, only one contained blaIMP-1, and none of 
them contained blaVIM-2 (Table 2). This result clearly suggests 
that in the P. aeruginosa clinical isolates tested in the current 
study, carbapenem resistance is not mediated by the presence 
of blaVIM-2 or blaIMP-1.
In addition, neither PCR nor LAMP reactions for blaVIM-2 and 
blaIMP-1 using the 75 CRAB and 24 CSAB isolates as templates 
produced amplicons. In contrast, a large number of A. bauman-
nii clinical isolates were found to have blaOXA-23, indicating that 
blaOXA-23 is a major genetic determinant of carbapenem resis-
tance in A. baumannii [16]. Among the 75 CRAB sputum spec-
imens, 52 were positive for the presence of blaOXA-23 by both 
PCR and LAMP (Table 3). There were 23 CRAB clinical speci-
mens that were negative for blaOXA-23 by PCR. Of these 23 PCR-
negative CRAB specimens, two had blaOXA-23 by LAMP. This re-
sult supports the notion that LAMP detection of antibiotic resis-
tance genes is more sensitive than conventional PCR. Among 
the 24 CSAB specimens, 13 were positive for blaOXA-23 by PCR 
and LAMP, demonstrating that the presence of blaOXA-23 would 
not always result in carbapenem resistance. In general, the re-
sults from the blaVIM-2, blaIMP-1, and blaOXA-23 PCR and LAMP as-
says agreed with each other, although the LAMP assay for bla-
OXA-23 was more sensitive than the PCR assay.
Fig. 2. Optimization of the reaction temperature and MgSO4 concentration for the blaVIM-2, blaIMP-1, and blaOXA-23 loop-mediated isothermal 
amplification (LAMP) assays. (A-C) Ten ng of DNA was used as a template, and the reaction was performed for 1 hr at the temperatures in-
dicated at the top. The ‘DW’ reaction was performed at 62°C. (D-F) Ten ng DNA was used as a template, and the reaction was performed 
for 1 hr with MgSO4 concentrations indicated at the top. LAMP reaction was performed at 62°C. ‘DW’ means distilled water used in replace 
of the template DNA as a negative control. The reaction products were loaded onto 1.5% agarose gel for analysis.
A
D
B
E
C
F
blaVIM-2
blaVIM-2
 M 57 59 61 63 65 67 DW
 M DW 0 1 2 3 4 5 6 7 8
 M DW 57 59 61 63 65 67 
 M DW 0 1 2 3 4 5 6 7 8
 M DW 57 59 61 63 65 67 (°C) 
 M DW 0 1 2 3 4 5 6 7 (mM)
blaIMP-1
blaIMP-1
blaOXA-23
blaOXA-23
2,000
2,000
1,000
1,000
500
500
100
100
Table 2. Detection of blaVIM-2 and blaIMP-1 by conventional PCR and 
LAMP assays in clinical isolates of Pseudomonas aeruginosa
Strain 
(N)
blaVIM-2 
PCR
blaVIM-2 LAMP blaIMP-1 
PCR
blaIMP-1 LAMP
+ - + -
CRPA + 0 0 0 + 1 1 0
(100) - 100 0 100 - 99 0 99
CSPA + 0 0 0 + 0 0 0
(20) - 20 0 20 - 20 0 20
+, positive reaction; -, negative reaction. P. aeruginosa clinical isolates were 
not tested for the presence of blaOXA-23.
Abbreviations: CRPA, carbapenem-resistant Pseudomonas aeruginosa; 
CSPA, carbapenem-susceptible Pseudomonas aeruginosa.
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Fig. 3. Determination of the detection limit of the loop-mediated isothermal amplification (LAMP) assays and the minimum reaction time. 
(A-C) Various amounts of template DNA (1 fg, 10 fg, 100 fg, 1 pg, 10 pg, 100 pg, 1 ng, or 10 ng) were used in the LAMP reactions. The 
amplification was performed with 2mM MgSO4 at 62°C for 1 hr. (D-F) LAMP reactions were performed for a range of reaction times. After 
the reaction time indicated on top of the gels, the LAMP reaction was terminated by inactivating Bst DNA polymerase by incubation at 95°C 
for 3 min. The reaction products were loaded onto a 1.5% agarose gel for analysis.
A
D
B
E
C
F
blaVIM-2
blaVIM-2
 M DW 10 ng 100 pg 1pg 10 fg
 M DW 10 15 20 25 30 35 40 45 50 55 60
 M DW 10 ng 100 pg 1pg 10 fg
 M DW 10 15 20 25 30 35 40 45 50 55 60
 M DW 10 ng 100 pg 1pg 10 fg
 M DW 10 15 20 25 30 35 40 45 50 55 (min)
blaIMP-1
blaIMP-1
blaOXA-23
blaOXA-23
2,000
2,000
1,000
1,000
500
500
100
100
DISCUSSION
Carbapenemase-producing strains are a worldwide concern, as 
some of these strains have acquired broad spectrum antibiotic 
resistance. In Korea, carbapenem-resistant bacteria frequently 
cause nosocomial infections, especially in intensive care units 
(ICUs). Among the deaths caused by infection, 54.2% were due 
to nosocomial infection [17]. Infections caused by multidrug-re-
sistant bacteria prolong the length of hospital stays and increase 
the medical expenses of immunocompromised patients in the 
ICU. To timely prescribe proper antibiotics for the treatment of 
multidrug-resistant infections, rapid and accurate diagnostic 
methods are required.
Growing a culture of the infecting bacteria must precede the 
routine diagnostic methods currently used to detect carbape-
nem-resistant organisms. For phenotype testing using antibiotic 
sensitivity, the two main methods are MHT and DDST [11, 13]. 
Additionally, various automated instruments that measure the 
MIC of resistant bacteria are used as diagnostic tests. Typically, 
the Vitek, MicroScan, and Phoenix are used [14]. Phenotype 
testing and automated instruments require cultured bacteria; 
Table 3. Detection of blaVIM-2, blaIMP-1, and blaOXA-23 by conventional 
PCR and LAMP assays in clinical isolates of A. baumannii
Strain 
(N)
blaVIM-2 
PCR
blaVIM-2 
LAMP blaIMP-1 
PCR
blaIMP-1 
LAMP blaOXA-23 
PCR
blaOXA-23 
LAMP
+ - + - + -
CRPA + 0 0 0 + 0 0 0 + 52 52 0
(75) - 75 0 75 - 75 0 75 - 23 2 21
CSPA + 0 0 0 + 0 0 0 + 13 13 0
(24) - 24 0 24 - 24 0 24 - 11 2 9
+, positive reaction; -, negative reaction.
Abbreviations: CRAB, carbapenem-resistant A. baumannii; CSAB, carbape-
nem-susceptible A. baumannii.
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therefore, the time required to complete these tests is usually 
16-20 hr. Although culture-dependent diagnostic tests are easy 
to perform, they are time-consuming and often require addi-
tional confirmation tests [18].
Molecular diagnostic methods are used when conventional 
culture-based methods are not sensitive enough, cost too much 
money, or take too long to complete. The most common molec-
ular diagnostic method is PCR. PCR-based diagnosis has also 
been used due to its ability to detect specific target genes. How-
ever, quantitative measurements of target genes are not always 
straightforward in PCR analyses, and the presence of the ampli-
fied products has to be confirmed by gel electrophoresis.
Rapid and reliable detection of CRPA and CRAB is very im-
portant in clinical environments. It is of note that Mg2+ concen-
tration optimal for each LAMP reaction was different. Further-
more, amplification of blaVIM-2 was achieved with only 20 min re-
action time, while 35 min and 40 min reactions were required 
to detect amplifications of blaIMP-1 and blaOXA-23, respectively. 
These results suggest that our reaction conditions are better op-
timized, compared with those described previously [19]. Based 
on our protocols, the minimum amount of DNA template for 
successful LAMP reaction was 100-1,000 fold less than that for 
PCR. This demonstrates that LAMP is certainly a superb diag-
nostic method, when fast and sensitive decision is necessary.
Our results using clinical isolates showed that carbapenem 
resistance in P. aeruginosa and A. baumannii is not related to 
the presence of blaVIM-2 or blaIMP-1. Lee et al. [20] reported that 
the prevalence of metallo-β-lactamase-producing P. aeruginosa 
decreased from 9% to 3% during the period between 2008 and 
2012. Likewise, infections caused by metallo-β-lactamase-
producing Acinetobacter spp. also decreased from 20% to 2% 
during the period between 2005 and 2012 [20]. These findings 
suggest that carbapenem resistance of P. aeruginosa and Aci-
netobacter spp. is likely mediated by other mechanisms that 
may involve activation of AmpC-type, OXA-type, or extended 
spectrum β-lactamases with porin loss [21, 22].
In this study, we present LAMP as a useful molecular diagno-
sis assay for CRPA and CRAB. For rapid detection, DNA sam-
ples were extracted from sputum specimens by using a mag-
netic bead-based method, which took less than 30 min. Then, 
the LAMP assay was immediately performed, and a positive re-
action was produced within 60 min. Our results also demon-
strated the usefulness of LAMP for detecting CRPA and CRAB 
infections in clinical specimens by targeting the blaVIM-2, blaIMP-1, 
and blaOXA-23 genes, which are critical for carbapenem resis-
tance.
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